These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30255734)
21. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites. Tyrawski J; DeAndrea DC J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738 [TBL] [Abstract][Full Text] [Related]
22. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. Matthews KR; Iltis AS BMC Med Ethics; 2015 Nov; 16(1):75. PubMed ID: 26537611 [TBL] [Abstract][Full Text] [Related]
23. Rejuvenating Regenerative Medicine Regulation. Charo RA; Sipp D N Engl J Med; 2018 Feb; 378(6):504-505. PubMed ID: 29320637 [No Abstract] [Full Text] [Related]
24. Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments. Master Z; Fu W; Paciulli D; Sipp D Clin Pharmacol Ther; 2017 Aug; 102(2):177-179. PubMed ID: 28695633 [TBL] [Abstract][Full Text] [Related]
25. Challenges in the Regulation of Autologous Stem Cell Interventions in the United States. Sipp D Perspect Biol Med; 2018; 61(1):25-41. PubMed ID: 29805146 [TBL] [Abstract][Full Text] [Related]
26. Online seminars as an information source for direct-to-consumer stem cell therapy. Hassoun M; Golub S; Greenfield S; Grill JD; Cummings BJ Regen Med; 2022 Feb; 17(2):81-90. PubMed ID: 34949108 [No Abstract] [Full Text] [Related]
27. Stem cell tourism and doctors' duties to minors--a view from Canada. Zarzeczny A; Caulfield T Am J Bioeth; 2010 May; 10(5):3-15. PubMed ID: 20461636 [TBL] [Abstract][Full Text] [Related]
30. Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions. Weiss DJ; Turner L; Levine AD; Ikonomou L Cytotherapy; 2018 Feb; 20(2):165-168. PubMed ID: 29239793 [TBL] [Abstract][Full Text] [Related]
31. Regulating the advertising and promotion of stem cell therapies. von Tigerstrom B Regen Med; 2017 Oct; 12(7):815-826. PubMed ID: 29112482 [TBL] [Abstract][Full Text] [Related]
32. Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns. Snyder J; Turner L Regen Med; 2018 Jun; 13(4):375-384. PubMed ID: 29985757 [TBL] [Abstract][Full Text] [Related]
33. Cell Churches and Stem Cell Marketing in South Korea and the United States. Sipp D Dev World Bioeth; 2017 Dec; 17(3):167-172. PubMed ID: 27214044 [TBL] [Abstract][Full Text] [Related]
34. High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease. Glassberg MK; Csete IS; Toonkel RL Chest; 2018 Jun; 153(6):1294-1295. PubMed ID: 29884248 [No Abstract] [Full Text] [Related]
35. Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. Ghinea N; Munsie M; Rudge C; Stewart C Regen Med; 2020 Feb; 15(2):1361-1369. PubMed ID: 32228372 [TBL] [Abstract][Full Text] [Related]
36. Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? Ogbogu U; Rachul C; Caulfield T Regen Med; 2013 May; 8(3):361-9. PubMed ID: 23627829 [TBL] [Abstract][Full Text] [Related]
37. Selling falsehoods? A cross-sectional study of Canadian naturopathy, homeopathy, chiropractic and acupuncture clinic website claims relating to allergy and asthma. Murdoch B; Carr S; Caulfield T BMJ Open; 2016 Dec; 6(12):e014028. PubMed ID: 27986744 [TBL] [Abstract][Full Text] [Related]
38. Direct-to-consumer advertising for robotic surgery. Thomas D; Medoff B; Anger J; Chughtai B J Robot Surg; 2020 Feb; 14(1):17-20. PubMed ID: 31243703 [TBL] [Abstract][Full Text] [Related]